Hancock Mark sold $8.1M of PACS
Hancock Mark (Co Fndr; Exec V Chair) sold 200,000 shares of PACS Group, Inc. (PACS) at an average of $40.38 ($40.33–$41.01, $8.08M total) across 3 trades over 2026-06-25 to 2026-06-26 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
An insider/10% owner sold ~$8.08M of shares across three trades at ~$40.33–$41.01, with a stated pre-arranged 10b5-1 plan.
Market read
Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a fundamental repricing.
What to watch
The filing does not state tax/financing needs, and the net effect on float/ownership is not provided beyond post-transaction holdings.
Background
The article is an SEC Form 4 insider transaction disclosure for PACS Group, Inc.
Ticker impact
PACS Group insider Hancock Mark sold about 200,000 shares in open-market transactions totaling ~$8.08M under a 10b5-1 plan.
Likely limited near-term impact; any effect is more sentiment/flow-related than fundamental.
Form 4 shows a pre-arranged 10b5-1 sale by an exec/10% owner, with no accompanying operational or financial guidance changes in the text.
Market effects
No sector-level implications; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may be routine diversification rather than a bearish signal.
Key entities
- issuerPACS Group, Inc.
Company whose insider transaction is disclosed on SEC Form 4.
- insiderHancock Mark
Co-founder; Exec V Chair and 10% owner who executed the open-market sale.
